Elanco Animal Health Incorporated (ETR:5EA)
Germany · Delayed Price · Currency is EUR 19.97
-0.13 (-0.67%)
At close: Nov 28, 2025
Elanco Animal Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 4,591 | 4,439 | 4,417 | 4,411 | 4,764 | 3,271 | Upgrade | |
Revenue Growth (YoY) | 3.08% | 0.50% | 0.14% | -7.41% | 45.64% | 6.51% | Upgrade |
Cost of Revenue | 2,068 | 2,003 | 1,931 | 1,913 | 2,068 | 1,577 | Upgrade |
Gross Profit | 2,523 | 2,436 | 2,486 | 2,498 | 2,696 | 1,694 | Upgrade |
Selling, General & Admin | 1,386 | 1,308 | 1,280 | 1,259 | 1,395 | 988 | Upgrade |
Research & Development | 356 | 344 | 327 | 321 | 369 | 329 | Upgrade |
Amortization of Goodwill & Intangibles | 534 | 527 | 548 | 528 | 556 | 360 | Upgrade |
Operating Expenses | 2,276 | 2,179 | 2,155 | 2,108 | 2,320 | 1,677 | Upgrade |
Operating Income | 247 | 257 | 331 | 390 | 376 | 17 | Upgrade |
Interest Expense | -186 | -235 | -277 | -241 | -236 | -150 | Upgrade |
Currency Exchange Gain (Loss) | -35 | -12 | -40 | -28 | -35 | -4 | Upgrade |
Other Non Operating Income (Expenses) | - | -12 | -12.5 | -10 | 22 | -60 | Upgrade |
EBT Excluding Unusual Items | 26 | -2 | 1.5 | 111 | 127 | -197 | Upgrade |
Merger & Restructuring Charges | -3 | -62 | -93 | -98 | -336 | -702 | Upgrade |
Impairment of Goodwill | - | - | -1,042 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 11 | Upgrade |
Gain (Loss) on Sale of Assets | - | 640 | - | - | - | 211 | Upgrade |
Asset Writedown | -29 | -81 | -32 | -81 | - | - | Upgrade |
Legal Settlements | - | - | -27.5 | - | -10 | - | Upgrade |
Other Unusual Items | -10 | -7 | -2 | -4 | -352 | - | Upgrade |
Pretax Income | -16 | 488 | -1,195 | -72 | -571 | -677 | Upgrade |
Income Tax Expense | -52 | 150 | 36 | 6 | -88 | -103 | Upgrade |
Net Income | 36 | 338 | -1,231 | -78 | -483 | -574 | Upgrade |
Net Income to Common | 36 | 338 | -1,231 | -78 | -483 | -574 | Upgrade |
Net Income Growth | -82.44% | - | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 496 | 494 | 492 | 488 | 487 | 441 | Upgrade |
Shares Outstanding (Diluted) | 501 | 497 | 492 | 488 | 487 | 441 | Upgrade |
Shares Change (YoY) | 0.93% | 1.02% | 0.82% | 0.23% | 10.38% | 19.20% | Upgrade |
EPS (Basic) | 0.07 | 0.68 | -2.50 | -0.16 | -0.99 | -1.30 | Upgrade |
EPS (Diluted) | 0.07 | 0.68 | -2.50 | -0.16 | -0.99 | -1.30 | Upgrade |
EPS Growth | -82.84% | - | - | - | - | - | Upgrade |
Free Cash Flow | 368 | 394 | 131 | 281 | 324 | -176 | Upgrade |
Free Cash Flow Per Share | 0.73 | 0.79 | 0.27 | 0.57 | 0.67 | -0.40 | Upgrade |
Gross Margin | 54.95% | 54.88% | 56.28% | 56.63% | 56.59% | 51.79% | Upgrade |
Operating Margin | 5.38% | 5.79% | 7.49% | 8.84% | 7.89% | 0.52% | Upgrade |
Profit Margin | 0.78% | 7.61% | -27.87% | -1.77% | -10.14% | -17.55% | Upgrade |
Free Cash Flow Margin | 8.02% | 8.88% | 2.97% | 6.37% | 6.80% | -5.38% | Upgrade |
EBITDA | 882 | 879 | 971 | 1,007 | 1,040 | 499 | Upgrade |
EBITDA Margin | 19.21% | 19.80% | 21.98% | 22.83% | 21.83% | 15.25% | Upgrade |
D&A For EBITDA | 635 | 622 | 640 | 617 | 664 | 482 | Upgrade |
EBIT | 247 | 257 | 331 | 390 | 376 | 17 | Upgrade |
EBIT Margin | 5.38% | 5.79% | 7.49% | 8.84% | 7.89% | 0.52% | Upgrade |
Effective Tax Rate | - | 30.74% | - | - | - | - | Upgrade |
Advertising Expenses | - | 236 | 207 | 201 | 248 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.